HLB Pharmaceutical Co. Ltd Free Cash Flow Generation Index
HLB Pharmaceutical Co. Ltd free cash flow generation index. HLB Pharmaceutical Co. Ltd (047920) has a Free Cash Flow Generation Index of -0.21x as of September 2025. Free cash flow of ₩-391.04 Million represents 0% of operating cash flow (₩1.86 Billion). Check 047920 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of HLB Pharmaceutical Co. Ltd (2014–2024)
Free cash flow generation index of HLB Pharmaceutical Co. Ltd from 2014 to 2024. Historical FCF Generation Index trend for HLB Pharmaceutical Co. Ltd across 3 annual periods. Explore HLB Pharmaceutical Co. Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
HLB Pharmaceutical Co. Ltd Free Cash Flow Generation Index by Year (2014–2024)
HLB Pharmaceutical Co. Ltd free cash flow generation index by year from 2014 to 2024. Year-by-year Free Cash Flow Generation Index for HLB Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see HLB Pharmaceutical Co. Ltd operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | ₩3.75 Billion | ₩6.84 Billion | ₩3.09 Billion | ▼ -73.0% |
| 2019 | 2.03x | ₩2.75 Billion | ₩1.35 Billion | ₩1.40 Billion | ▼ -17.6% |
| 2014 | 2.47x | ₩3.80 Billion | ₩1.54 Billion | ₩2.26 Billion | — |